Changsha Biovision Software Technology Co., Ltd. was founded in 2009 in the Changsha High-tech Zone as a government-introduced international talent and technology programme. The company develops medical IT and clinical AI products, with more than 50 products in-house. Per public statements, its systems run in over 4,000 healthcare institutions and it has built more than 80 municipal and county-level regional healthcare platforms across Hunan, Shanghai, Hubei, Guangxi, Yunnan, Sichuan, Hebei and Guizhou.
The portfolio is organised in four layers: departmental systems for radiology, ultrasound, endoscopy, pathology, nuclear medicine and ECG; hospital-wide PACS and the ECG network as the backbone; regional consortium platforms and a city-level medical AI brain; and an intelligence layer of 3D AI analysis, CDSS, EMR quality control and RPA automation. Its in-house 101 heterogeneous data acquisition technology addresses multi-vendor data silos in hospitals.
Products
- Enterprise PACS (3D + AI) — hospital-wide imaging with 3D post-processing and AI lesion analysis
- Ultrasound Information System — acquisition, reporting, review and records in one system
- Endoscopy Information System — multi-scope compatibility with 1080P capture
- Pathology Information and QC System — six workstations with barcode traceability
- ECG Network System — automated measurement, interpretation and critical-value alerts
- Regional Medical Consortium Platform — regional PACS / LIS / ECG and tele-consultation
- City-level Medical AI Brain — knowledge graph and rule engine for primary care
- Xiaobang RPA Robot — API-free cross-system data movement
The company is a High-tech Enterprise holding medical device manufacturing and product registration qualifications. Its RPA robotic process automation technologies received the 2022–2023 Hunan Provincial Technological Invention Award, third prize.
https://en.bowei.xiangqishow.com/